Health
Saccharin, an artificial sweetener, has a history of cancer concerns. Studies link saccharin to bladder cancer in lab animals, prompting its 1981 listing as a potential carcinogen by the U.S. National Toxicology Program. Though delisted in 2000, evidence remains inconclusive about its safety in humans. CSPI emphasizes caution: saccharin's widespread use poses unnecessary risks, especially when safer alternatives like stevia exist. With millions exposed daily, protecting public health means choosing proven-safe sweeteners over saccharin.
Extensive research shows saccharin does not cause cancer in humans. Studies leading to its delisting from the carcinogen list found no link between saccharin and bladder cancer in humans, and regulatory agencies deem it safe for consumption worldwide.
Saccharin does not cause cancer. Over 30 years of robust NIH research show no correlation between saccharin consumption and tumor development. This widely used sweetener was removed from the U.S. National Toxicology Program’s list of possible carcinogens in 2000. Alarmist claims ignore settled science and sow needless fear. The National Cancer Institute endorses evidence-based information, emphasizing saccharin’s safety and urging the public to reject baseless myths that distract from genuine cancer risks.
Animal studies link saccharin to bladder tumors at high doses (EPA), overshadowing claims of complete safety. The FDA once proposed banning saccharin, reflecting persistent cancer concerns. Minimizing these risks endangers public trust and health.